Skip to main content
Back to Korea Investment Partners

Korea Investment Partners's Biotechnology Portfolio

Browse 38 Biotechnology companies funded by Korea Investment Partners. See funding amounts, founder contacts, and investment details.

Biotechnology Companies
38
Total Funding in Biotechnology
$678.0M

Biotechnology Portfolio Companies (38)

Export
BiotechnologyGeneticsHealth Care

Eloxx Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel RNA-modulating drug candidates.

Waltham, United States
June 2026
$66.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyMedicalOncologyTherapeuticsWellness

PineTree Therapeutics engages in the development of disruptive therapies in Oncology and Immuno-oncology.

Cambridge, United States
October 2025
$47.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyManufacturingPharmaceutical

Pin Therapeutics is a pharmaceutical startup focusing on advanced protein degradation therapeutics.

Seongnam, South Korea
December 2024
$13.6M
Series C

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyGeneticsTest and Measurement

Bio Design Lab is a biotechnology company that develops biopharmaceutical products.

Pohang, South Korea
October 2024
$5.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyMedicalMedical DeviceOncology

Actym Therapeutics is a biotech company that focuses on the discovery and development of novel immuno-oncology therapies to treat cancer.

Berkeley, United States
October 2023
$25.5M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareOncologyPharmaceuticalTherapeutics

Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.

Plymouth Meeting, United States
September 2023
$5.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedical

ABL Bio is a biotech research company that focuses on the development of therapeutic drugs for immuno-oncology diseases.

Seongnam, South Korea
September 2023
$3.0M
Venture - Series Unknown

Founder Contacts

41,000+ verified contacts

BiotechnologyGeneticsHealth CareOncologyPharmaceutical

Prokarium is biopharmaceutical company leading the oncology field of microbial immunotherapy.

London, United Kingdom
February 2023
$30.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareManufacturing

Univercells is a One-stop-shop for high-density low-cost biomanufacturing "end-to-end" solutions

Gosselies, Belgium
October 2022
$43.3M
Series D

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyHealth CareMedical DevicePharmaceuticalPrecision Medicine

OncXerna Therapeutics offers precision medicine using an innovative RNA-based biomarker platform.

Waltham, United States
March 2022
$30.0M
Venture - Series Unknown

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth DiagnosticsMedicalTherapeutics

OncoMyx Therapeutics develops oncolytic immunotherapies to assist in creating an immune response and treat cancer.

Phoenix, United States
December 2021
$50.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareTherapeutics

PDC*line Pharma develops a new class of active immunotherapies for cancer based on an allogeneic cell line of plasmacytoid dendritic cells.

La Tronche, France
December 2021
$13.3M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth Care

Virogin Biotech is an antineoplastic drug developer.

Vancouver, Canada
September 2021
$120.0M
Series D

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareProduct Research

MAXVAX aims to provide novel vaccine development and commercialization.

Shuangliu, China
December 2025
Series D

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareInformation Technology

Pharos iBio Co. specializing in drug development that develops treatments for intractable diseases.

Anyang, South Korea
December 2025
$12.9M
Post Ipo Debt

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

MicrobiotiX develops bacteriophage and microbiome-based therapeutics to combat multidrug-resistant infections and autoimmune diseases.

Seoul, South Korea
August 2025
$3.6M
Series B

Founder Contacts

41,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyMedicalPharmaceutical

Selta Square is an AI-based drug monitoring company that offers full-cycle drug monitoring solutions using AI technology.

Seoul, South Korea
January 2025
$6.4M
Series A

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyPharmaceutical

Mepsgen is a biotechnology research organization that focuses on pharmaceutical services and drug development.

Seoul, South Korea
November 2024
$14.9M
Series C

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyManufacturingPharmaceutical

Innogen Pharmaceutical Technology is a high-tech, innovation-driven international pharmaceutical manufacturing and R&D company.

Shanghai, China
January 2024
Private Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedical Device

Caremedi is a wearable drug pump and healthcare company.

Seoul, South Korea
November 2023
$20.0M
Series B

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyMedical

Brexogen is a biotechnology cell therapy research and development company.

Seoul, South Korea
September 2023
$9.1M
Series C

Founder Contacts

41,000+ verified contacts

BiotechnologyDentalHealth CareMedical

Hisense Bio offers treatment for intractable dental diseases using physiological and periodontal ligament regeneration technology.

Seongnam, South Korea
July 2023
$8.9M
Series Unknown

Founder Contacts

41,000+ verified contacts

BiotechnologyLife SciencePharmaceutical

Biomatz is a biotech company developing AI-driven microbiome therapeutics using cooperative multi-strain design.​

Seoul, South Korea
June 2023
$1.5M
Seed

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth Care

Genome & Co (G&C) is a microbiome based research and development company focused on researching microbes and probiotics.

Suwon, South Korea
April 2023
$17.5M
Convertible Note

Founder Contacts

41,000+ verified contacts

BiotechnologyMedicalTest and Measurement

Tcino Bioscience develops molecule anti-cancer drugs for cancer patients.

Yongin, South Korea
March 2023
$1.5M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyGeneticsHealth CareMedical

Medizen Humancare personalized healthcare company that offers genetic analysis and disease prediction services.

Songpadong, South Korea
January 2023
$1.6M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyMedicalNeurosciencePharmaceutical

S&E Bio is a biopharmaceutical company that develops cell therapies for neurological disorders.

Seoul, South Korea
November 2022
$7.7M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyManufacturingPharmaceutical

Zhenge Biotech is a macromolecular pharmaceutical contract development and manufacturing organisation.

Shanghai, China
August 2022
$14.7M
Series C

Founder Contacts

41,000+ verified contacts

BiotechnologyClean EnergyFuel

Doosan Mobility Innovation focuses on the mobile applications of fuel cell technology.

Yongin, South Korea
April 2022
$22.2M
Series Unknown

Founder Contacts

41,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyInformation Technology

HITS is a biotech company that creates digital solutions to accelerate drug development and introduce a new drug discovery paradigm.

Seoul, South Korea
February 2022
$4.6M
Series A

Founder Contacts

41,000+ verified contacts

Biotechnology

ImmunoBiome is a biotech company developing microbiome therapeutics to treat incurable diseases like autoimmune diseases.

Pohang, South Korea
September 2021
$18.0M
Series B

Founder Contacts

41,000+ verified contacts

3D TechnologyBiotechnologyMedical

Cell in Cells researches and develops cell therapy products for regenerative medicine through the 3D technology of stem cells.

Seoul, South Korea
July 2021
$10.4M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyClinical TrialsLife SciencePharmaceutical

TSD Life Sciences is a bio company that provides clinical research services to defeat cancer through research and development.

Seoul, South Korea
June 2021
$8.8M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedicalPrecision Medicine

Gencurix is a biotechnology company that offers diagnostic solutions to facilitate personalized treatment.

Seoul, South Korea
June 2021
$24.4M
Series Unknown

Founder Contacts

41,000+ verified contacts

AnalyticsBiotechnologyPrecision Medicine

Geninus is a biotechnology company that provides clinical genome analysis solutions for precision medicine clinics.

Seoul, South Korea
August 2020
$13.3M
Series Unknown

Founder Contacts

41,000+ verified contacts

BiotechnologyDentalHealth CareSales

eBrace specializes in the research, development, production and sales of orthodontic biomaterials.

Guangzhou, China
July 2020
$2.9M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareTherapeutics

ExcelMab develops a series of anti-tumor bispecific antibody drugs for cancer patients.

Guangzhou, China
March 2020
$1.4M
Series A

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyMedical

EuBiologics provides and develops biopharmaceutical products.

Seoul, South Korea
October 2018
Series Unknown

Founder Contacts

41,000+ verified contacts

Explore Korea Investment Partners's Full Portfolio

View all companies funded by Korea Investment Partners across every industry and funding stage.

View Full Korea Investment Partners Portfolio